Literature DB >> 28527056

Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α1-agonists.

G D'Andrea1, G Bussone2, P Di Fiore2, F Perini3, A Gucciardi4, A Bolner5, M Aguggia6, G Saracco6, E Galloni3, G Giordano7, A Leon5.   

Abstract

The aim of this study was to explore the possible role of tryptamine in the pathogenesis of chronic cluster headache along with that of adrenaline and noradrenaline (α-agonists) together with arginine metabolism in the origin of cluster bouts. Plasma levels of tyramine, tryptamine, serotonin, 5-hydroxyindolacetic acid, noradrenalin, adrenalin and the markers of arginine metabolism such as arginine, homoarginine, citrulline, ADMA and NMMA, were measured in 23 chronic cluster headache patients (10 chronic cluster ab initio and 13 transformed from episodic cluster) and 28 control subjects. The plasma levels of tyramine, tryptamine, noradrenalin and adrenalin were found several times higher in chronic cluster headache patients compared to controls, whereas the plasma levels of arginine, homoarginine and citrulline were significantly lower. No differences were found in the plasma levels of serotonin, 5-hydroxyindolacetic, ADMA and NMMA between chronic cluster headache patients and control subjects. These results provide support for a role of tryptamine in the pathogenesis of chronic cluster headache and, in particular, in the duration of the cluster bouts. In addition, the low levels of the nitric oxide substrates together with the high levels of noradrenalin and adrenalin suggest an activation of endothelial TAAR1 receptors followed by the release of nitric oxide in the circulation that may constitute the final step of the physiopathology of cluster crisis.

Entities:  

Keywords:  Arginine metabolism; Cluster headache; Noradrenaline; Trace amines; Tryptamine

Mesh:

Substances:

Year:  2017        PMID: 28527056     DOI: 10.1007/s10072-017-2862-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Activation of serotonin 1A receptors in ventrolateral orbital cortex depresses persistent nociception: a presynaptic inhibition mechanism.

Authors:  Fu-Quan Huo; Fen-Sheng Huang; Bo-Chang Lv; Tao Chen; Jie Feng; Chao-Ling Qu; Jing-Shi Tang; Yun-Qing Li
Journal:  Neurochem Int       Date:  2010-09-08       Impact factor: 3.921

2.  Evaluation of interictal autonomic function during attack and remission periods in cluster headaches.

Authors:  Ozlem Altiokka; Belgin Mutluay; Ayhan Koksal; Beyza Ciftci-Kavaklioglu; Musa Ozturk; Yavuz Altunkaynak; Sevim Baybas; Aysun Soysal
Journal:  Cephalalgia       Date:  2015-04-02       Impact factor: 6.292

3.  Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages.

Authors:  Giovanni D'Andrea; Gianpietro Nordera; Gilberto Pizzolato; Andrea Bolner; Davide Colavito; Raffaella Flaibani; Alberta Leon
Journal:  Neurosci Lett       Date:  2009-12-21       Impact factor: 3.046

Review 4.  Multiple roles of serotonin in pain control mechanisms--implications of 5-HT₇ and other 5-HT receptor types.

Authors:  Florent Viguier; Benoît Michot; Michel Hamon; Sylvie Bourgoin
Journal:  Eur J Pharmacol       Date:  2013-03-13       Impact factor: 4.432

5.  Serotonin metabolism in cluster headache.

Authors:  G D'Andrea; F Granella; M Alecci; G C Manzoni
Journal:  Cephalalgia       Date:  1998-03       Impact factor: 6.292

Review 6.  Pathogenesis of migraine: role of neuromodulators.

Authors:  Giovanni D'Andrea; Antonello D'Arrigo; Maurizio Dalle Carbonare; Alberta Leon
Journal:  Headache       Date:  2012-06-01       Impact factor: 5.887

Review 7.  The vascular effects of trace amines and amphetamines.

Authors:  Kenneth J Broadley
Journal:  Pharmacol Ther       Date:  2009-12-04       Impact factor: 12.310

8.  Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle.

Authors:  Brenda R Flam; Duane C Eichler; Larry P Solomonson
Journal:  Nitric Oxide       Date:  2007-08-03       Impact factor: 4.427

9.  Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine.

Authors:  M A Anwar; W R Ford; K J Broadley; A A Herbert
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

10.  Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation.

Authors:  Dimos D Mitsikostas; Lars Edvinsson; Rigmor H Jensen; Zaza Katsarava; Christian Lampl; Andrea Negro; Vera Osipova; Koen Paemeleire; Aksel Siva; Dominique Valade; Paolo Martelletti
Journal:  J Headache Pain       Date:  2014-11-27       Impact factor: 7.277

View more
  2 in total

Review 1.  Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache.

Authors:  Roger Gregory Biringer
Journal:  Mol Cell Biochem       Date:  2022-04-28       Impact factor: 3.842

Review 2.  Update on the pathophysiology of cluster headache: imaging and neuropeptide studies.

Authors:  Alina Buture; Jason W Boland; Lisa Dikomitis; Fayyaz Ahmed
Journal:  J Pain Res       Date:  2019-01-04       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.